Publications

Use of Slingshot CTx TruCytes CD34 for assay sensitivity testing

A Workflow for Spectral Compensation with SpectraComp Synthetic Cell Controls

Use of Slingshot CTx TruCytes CD34 for assay sensitivity testing

Hydrogels Mimicking T, B and NK Cells for Quality Assurance in Cell Therapy Development

Advancing Flow Cytometry with a Novel Antigen Quantification Method – 2024

Enhancing Immunophenotyping Standardization in Clinical Labs with Quantitative BCMA or CD19 Cell Mimics

CD34 Stem Cell Mimics as reliable controls for Cell Therapy

Cell Mimics as Robust Positive Controls for Immunodeficiency Analyses

Standardization and Calibration of Flow Cytometry Using Synthetic Cells with Multi-level Forward and Side Scatter

Development of non-biohazardous p24 antigen expressing cell mimics as a reference control alternative to HIV+ donor sample

Next-generation cell mimics double as apoptosis controls and efficient flow cytometry training tools

Navigating the opportunities and challenges in analytical development of flowcytometry for T cell therapy

Accessing prognosis by quantifying Fc RIIa on fixed platelets – Prolocor and Slingshot Biosciences

Davis, P. M., Ravkov, E., M. de Geus, Clauss, Z., Lee, J., Nguyen, A. T., Hartmann, M., Kim, J., George, T. I., Lin, L., & Ng, D. P. (2024). Synthetic abnormal mast cell particles successfully mimic neoplastic mast cells by flow cytometry. Cytometry Part B: Clinical Cytometry, 1–11.

Jensen, Holly A, and Jeong Kim. “iCoreDrop – A robust immune monitoring spectral cytometry assay with six open channels for biomarker flexibility.” Cytometry. Part A : the journal of the International Society for Analytical Cytology vol. 103,5 (2023): 405-418. doi:10.1002/cyto.a.24708

We Need to Talk About Flow Cytometry – Nature Article 2023

Controls on Demand: Revolutionizing The Drug Discovery Pipeline – MedHealth Outlook 2022